MED vs NUS
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Aug 04, 2026
MED
NUS
Investment Advisor Scores
NUS
AI Analyst Insights
Detailed Metrics Comparison
| Metric | MED | NUS | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 12.4844 | 5.1894 | NUS |
| PEG Ratio | 0.972 | 0.7782 | NUS |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -34.3% | -12.0% | NUS |
| Earnings Growth | -87.2% | -98.2% | MED |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 46.5/100 | 44.1/100 | MED |
| Profit Margin | -5.8% | 3.8% | NUS |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
MED
MarkdownPrice below a falling SMA50 (slope -5.7%), weak momentum, RSI 39
NUS
DistributionPrice near a flattening SMA50 (slope -11.0%) with fading momentum, RSI 46
Fundamentals Snapshot
| Metric | MED | NUS |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | -16.5 | 3.9 |
| Trailing P/E | — | 4.8 |
| Revenue (TTM) | — | — |
| Revenue Growth | -0.3% | -0.1% |
| Gross Margin | 0.7% | 0.7% |
| Operating Margin | -0.1% | 0.0% |
| EPS | -1.82 | 1.08 |
| Dividend Yield | — | 0.05% |